What question did this study set out to answer?

To review the immunomodulatory and anti-apoptotic cellular mechanisms through which levosimendan improves cardiac contractile performance in decompensated heart failure.

July 1, 2005Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Anti-Inflammatory and Anti-Apoptotic Effects of Levosimendan in Decompensated Heart Failure: A Novel Mechanism of Drug-Induced Improvement in Contractile Performance of the Failing Heart

View Full Paper

Ask AI

Bookmark

Population

Patients with severe heart failure due to left ventricular systolic dysfunction (decompensated heart failure)

Design

Review

Authors

IPIoannis ParaskevaidisHeart Failure & Transplant JPJohn ParissisHeart Failure & Transplant DKDimitios Th KremastinosOnassis Cardiac Surgery Center

Discussion

Member takes

Implication

Does not support changing levosimendan use in decompensated HF; leaves open whether cytokine reduction mediates benefit.

Key Points

To review the immunomodulatory and anti-apoptotic cellular mechanisms through which levosimendan improves cardiac contractile performance in decompensated heart failure.
Narrative synthesis of preclinical research and large-scale randomized clinical trials investigating levosimendan in patients with severe heart failure and left ventricular systolic dysfunction.
Levosimendan enhances cardiac contractility by sensitizing troponin C to calcium without impairing diastolic relaxation and causes vasodilation through opening ATP-dependent potassium channels.
Treatment suppresses circulating levels of major pro-inflammatory cytokines (TNF-alpha, IL-6) and soluble apoptotic signaling proteins (Fas/Fas Ligand), correlating with improved clinical status and reduced short-term morbidity and mortality.

Structured PICO

Population

Patients with severe heart failure due to left ventricular systolic dysfunction (decompensated heart failure)

Intervention

Levosimendan

Levosimendan may improve contractile performance in decompensated heart failure through novel immunomodulatory and anti-apoptotic mechanisms, in addition to its known calcium-sensitizing and vasodilatory effects.

Cite This Study

Paraskevaidis et al. (2005) studied this question.

synapsesocial.com/papers/6a9b2d4fbf078dcd68397a8e https://doi.org/10.2174/1568016054368232

Topics

Heart failure HFrEF treatment

View Full Paper

Ask AI

Bookmark

Anti-Inflammatory and Anti-Apoptotic Effects of Levosimendan in Decompensated Heart Failure: A Novel Mechanism of Drug-Induced Improvement in Contractile Performance of the Failing Heart

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Anti-Inflammatory and Anti-Apoptotic Effects of Levosimendan in Decompensated Heart Failure: A Novel Mechanism of Drug-Induced Improvement in Contractile Performance of the Failing Heart

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider